Lecanemab (Leqembi)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lecanemab (Leqembi), covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid [Phase 3]